Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine
on
Get link
Facebook
X
Pinterest
Email
Other Apps
CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...
Comments
Post a Comment